R.H. Bluestein & Co’s Sotera Health SHC Stock Holding History

R.H. Bluestein & Co’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,000	Closed	-$267K	–	438
2021 Q2	$267K	Hold	11,000	–	–	0.01%	352
2021 Q1	$275K	Buy	+11,000	New	+$291K	0.01%	335

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

R.H. Bluestein & Co's SHC Position: Q3 2021 in Review

R.H. Bluestein & Co sold out of Sotera Health (SHC) in Q3 2021, closing a stake of 11,000 shares — an estimated $267K sold.

R.H. Bluestein & Co first reported a position in SHC in Q1 2021 and held it in 2 quarters. The position peaked at $275K in Q1 2021. 140 funds tracked by Wall St. Rank hold SHC as of Q3 2021.

R.H. Bluestein & Co reported no remaining Sotera Health position as of Q3 2021 after selling out during the quarter.
R.H. Bluestein & Co sold 11,000 Sotera Health shares in Q3 2021, an estimated $267K.
R.H. Bluestein & Co first reported a position in Sotera Health in Q1 2021 and held it in 2 quarters.
R.H. Bluestein & Co's Sotera Health position peaked at $275K in Q1 2021.
140 funds tracked by Wall St. Rank held Sotera Health as of Q3 2021.

Based on R.H. Bluestein & Co's 13F filing for Q3 2021, filed 12 Nov 2021.